Tatva Chintan Pharma Chem Limited (TATVA) Stock Statistics & Valuation Metrics

Tatva Chintan Pharma Chem Limited has a market cap or net worth of ₹24.73B. The enterprise value is ₹16.10B.

Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding. The number of shares has decreased by -2.65% in one year.

Tatva Chintan Pharma Chem Limited’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 12.70%.

The current PE Ratio of Tatva Chintan Pharma Chem Limited is 345.7. Tatva Chintan Pharma Chem Limited’s PEG ratio is -3.55.

In the last 12 months, Tatva Chintan Pharma Chem Limited had revenue of 3.83B and earned 57.13M in profits. Earnings per share was 2.44.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Tatva Chintan Pharma Chem Limited pays an annual dividend of ₹2, resulting in a dividend yield of 0.19%

Tatva Chintan Pharma Chem Limited upcoming earnings date is Oct 31, 2025, Before Open (Confirmed).

Tatva Chintan Pharma Chem Limited as a current ratio of 2.76, with Debt / Equity ratio of 4.93%

In the past 12 months, Tatva Chintan Pharma Chem Limited has paid 18.66M in taxes.

Tatva Chintan Pharma Chem Limited EV to EBITDA ratio is 49.05, with an EV/FCF ratio of -32.52.

Tatva Chintan Pharma Chem Limited has ₹140.96M in cash and marketable securities with ₹363.88M in debt, giving a net cash position of ₹222.92M billion.

Gross margin is 49.18%, with operating margin of 34.19%, and net profit margin of 1.49%.

The average price target for Tatva Chintan Pharma Chem Limited is ₹1,219.00, which is 11.43% higher than the current price. The consensus rating is Hold